.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Julphar
Daiichi Sankyo
Federal Trade Commission
Deloitte
Cantor Fitzgerald
Argus Health
US Army
Accenture
Harvard Business School

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,752,543

« Back to Dashboard

Which drugs does patent 8,752,543 protect, and when does it expire?


Patent 8,752,543 protects FLONASE SENSIMIST ALLERGY RELIEF and is included in one NDA.

This patent has forty patent family members in twenty-one countries.

Summary for Patent: 8,752,543

Title:Fluid dispensing device
Abstract: A fluid dispensing device for dispensing a fluid having a viscosity of from 10 to 2000 mPas at 25.degree. C., the dispensing device having at least one finger-operable lever pivotably moveable into the housing transversely with respect to the longitudinal axis of the fluid discharge device, to apply a force to an actuating member connected to the neck of a container, the device having a pre-load to prevent pivoting until a pre-determined force is applied, wherein the actuating member and the lever have surfaces which slidingly interact, wherein the pre-load is formed by one of the surfaces of the actuating member or the lever having a dual-gradient profile.
Inventor(s): Davies; Michael Birsha (Hertfordshire, GB), Hedley; Mark Graham (Hertfordshire, GB), Jones; Margot Jean (Hertfordshire, GB)
Assignee: Glaxo Group Limited (Brentford, Middlesex, GB)
Application Number:10/577,977
Patent Claim Types:
see list of patent claims
Use; Formulation; Device; Compound; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Glaxosmithkline ConsFLONASE SENSIMIST ALLERGY RELIEFfluticasone furoateSPRAY, METERED;NASAL022051-002Aug 2, 2016OTCYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,752,543

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0325629.4Nov 3, 2003
United Kingdom0405477.1Mar 11, 2004
United Kingdom0420539.9Sep 17, 2004
PCT Information
PCT FiledNovember 02, 2004PCT Application Number:PCT/GB2004/004626
PCT Publication Date:May 19, 2005PCT Publication Number: WO2005/044354

Non-Orange Book Patents for Patent: 8,752,543

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,147,461Fluid dispensing device► Subscribe
9,320,862Fluid dispensing device► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,752,543

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2010246483► Subscribe
BrazilPI0416128► Subscribe
BrazilPI0508586► Subscribe
Canada2544378► Subscribe
Canada2559099► Subscribe
China1901958► Subscribe
China1930054► Subscribe
China101723143► Subscribe
China102028994► Subscribe
Cyprus1112315► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Covington
Cerilliant
Johnson and Johnson
Teva
Moodys
Cipla
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot